Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ EmoryfiledCriticalUniv Emory
Publication of MY113560ApublicationCriticalpatent/MY113560A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
THE USE OF A 1,3-OXATHIOLANE NUCLEOSIDE ANALOGUE AND PHARMACEUTICALLY ACCEPTABLE DERIVATIVES THEREOF FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS IS DISCLOSED. PHARMACEUTICAL FORMULATIONS ARE ALSO PROVIDED.
MYPI92000358A1991-03-061992-03-05Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b
MY113560A
(en)
APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS
Use of lamivudine or pharmaceutically acceptable derivatives thereof for the manufacture of pharmaceutical compositions for use in the treatment or prophylaxis of viral infections